- Info
- Significant Ownership
- Insider Ownership
Significant Ownership of Datuk Dr. Doris Wong Sing Ee
- Signature - Title
- /s/ Datuk Dr. Doris Wong Sing Ee - Chief Executive Officer and Executive Director
- Location
- Wilayahpersekutuankuala Lumpur, Malaysia
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Datuk Dr. Doris Wong Sing Ee.
Follow Filing Activity
Follow Datuk Dr. Doris Wong Sing Ee and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Datuk Dr. Doris Wong Sing Ee
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CYCC | Cyclacel Pharmaceuticals, Inc. | Common Stock, par value $0.0001 per share | 70% | $58,388,646 | 194,628,820 | Doris Wong Sing Ee | 26 Feb 2025 | ||
| BGMS | Bio Green Med Solution, Inc. | Common Stock, par value $0.0001 per share | 21% | $5,555,655 | 1,111,131 | Doris Wong Sing Ee | 12 Nov 2025 |
Schedules 13D/G Reported by Datuk Dr. Doris Wong Sing Ee:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.